journal article·2021Open access

Coronavirus: A “Mild” Virus Turned Deadly Infection

Rizwan Ali Naqvi, Muhammad Faheem Mushtaq, Natash Ali Mian, Muhammad Adnan Khan, Atta-ur-Rahman, Muhammad Ali Yousaf, Muhammad Umair, Rizwan Majeed

Computers, Materials & Continua· Volume 67· Issue 2

Abstract

Coronaviruses are a family of viruses that can be transmitted from one person to another. Earlier strains have only been mild viruses, but the current form, known as coronavirus disease 2019 (COVID-19), has become a deadly infection. The outbreak originated in Wuhan, China, and has since spread worldwide. The symptoms of COVID-19 include a dry cough, sore throat, fever, and nasal congestion. Antimicrobial drugs, pathogen–host interaction, and 2 weeks of isolation have been recommended for the treatment of the infection. Safe operating procedures, such as the use of face masks, hand sanitizer, handwashing with soap, and social distancing, are also suggested. Moreover, travel bans for cities, states, and countries have been put in place, along with lockdowns to control the outbreak. Travel restrictions, mask use, sanitizer or soap use, and avoidance of touching the face and nose have produced encouraging results, whereas the effectiveness of antibiotics has not been proved. The results of isolation for the recovery of infected people have also been promising. Travel bans and lockdowns have caused a slump in economies, and unemployment has risen sharply, resulting in an increase in mental health cases globally. To date, vaccines have been developed and are in use in certain countries, but following standard operating procedures remain critical. The countries following the guidelines can eradicate this virus. New Zealand was the first country to eliminate the virus from their territory.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: COVID-19 epidemiological studies · COVID-19 and Mental Health · COVID-19 Pandemic Impacts

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. 2020. https://www.who.int/news-room/q-a-detail/q-a-coronaviruses.
2. 2020. https://who.sprinklr.com/.
3. 2020. https://www.bloomberg.com/news/articles/2020-03-05/here-s-all-the-cash-asian-nations-have-pledged-for-virus-relief.
4. 2020. https://www.bloomberg.com/markets/stocks.
5. 2020. https://www.bloomberg.com/markets/commodities.
6. 2020. https://www.bls.gov/news.release/pdf/empsit.pdf.
7. 2020. https://data.oecd.org/gdp/real-gdp-forecast.htm.
8. New coronavirus outbreak: Framing questions for pandemic prevention10.1126/scitranslmed.abb1469 ↗
9. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed10.1016/S2215-0366(20)30046-8 ↗
10. Novel coronavirus outbreak in Wuhan, China, 2020: Intense surveillance is vital for preventing sustained transmission in new locations10.3390/jcm9020498 ↗
11. The continuing 2019-NCOV epidemic threat of novel coronaviruses to global health–-the latest 2019 novel coronavirus outbreak in Wuhan10.1016/j.ijid.2020.01.009 ↗
12. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak-United States10.1111/ajt.15805 ↗
13. Effects of misleading media coverage on public health crisis: A case of the 2019 novel coronavirus outbreak in China
14. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the chinese center for disease control and prevention10.1001/jama.2020.2648 ↗
15. An updated estimation of the risk of transmission of the novel coronavirus10.1016/j.idm.2020.02.001 ↗
16. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: An experience from Hong Kong
17. Novel coronavirus outbreak: A quiz or final exam?10.1007/s11684-020-0753-1 ↗
18. A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units10.1016/S2352-4642(20)30040-7 ↗
19. Which lessons shall we learn from the 2019 novel coronavirus outbreak?10.21037/atm.2020.02.06 ↗
20. The novel coronavirus outbreak: A challenge beyond borders10.37978/pjsm.v1i1.126 ↗
21. The novel coronavirus: A bird’s eye view10.15171/ijoem.2020.1921 ↗
22. Estimating the unreported number of novel coronavirus cases in China in the first half of January 2020: A data–driven modelling analysis of the early outbreak10.3390/jcm9020388 ↗
23. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus10.1016/S2215-0366(20)30047-X ↗
24. Coronavirus infections–-more than just the common cold10.1001/jama.2020.0757 ↗
25. Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: Protocol of a randomized controlled trial
26. First case of 2019 novel coronavirus in the United States10.1056/NEJMoa2001191 ↗
27. The origin, transmission and clinical therapies on coronavirus disease 2019 outbreak-an update on the status10.1186/s40779-020-00240-0 ↗
28. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus, December 2019 to January 2020
29. The reproductive number of covid-19 is higher compared to SARS coronavirus10.1093/jtm/taaa021 ↗
30. The novel coronavirus originating in Wuhan, China: Challenges for global health governance10.1001/jama.2020.1097 ↗
31. Clinical findings in a group of patients infected with the 2019 novel coronavirus outside of Wuhan, China: Retrospective case series
32. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China10.1001/jama.2020.1623 ↗
33. Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) and corona virus disease-2019 (COVID-19): The epidemic and the challenges10.1016/j.ijantimicag.2020.105924 ↗
34. Coronavirus disease 2019 (COVID-19): Role of chest ct in diagnosis and management10.2214/AJR.20.22954 ↗
35. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: Experts’ consensus statement
36. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus
37. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis
38. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia10.1002/jmv.25742 ↗
39. Laboratory diagnosis of emerging human coronavirus infections-the state of the art10.1080/22221751.2020.1745095 ↗
40. Diagnosis and treatment of 2019 novel coronavirus infection in children: A pressing issue
41. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 201910.1016/j.ijid.2020.03.065 ↗
42. Molecular immune pathogenesis and diagnosis of COVID-1910.1016/j.jpha.2020.03.001 ↗
43. Diagnostic testing for SARS-coronavirus-2 in the nursing facility: Recommendations of a Delphi panel of long-term care clinicians10.1007/s12603-020-1401-9 ↗
44. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease-2019 (COVID-19): A cross-sectional study
45. A first case of meningitis/encephalitis associated with SARS-coronavirus-210.1016/j.ijid.2020.03.062 ↗
46. Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020
47. Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions10.21037/jtd.2020.02.64 ↗
48. Modeling and forecasting trend of COVID-19 epidemic in Iran until May 13, 2020